|
Prevention and
treatment scheme of integrated traditional Chinese and western medicine for
respiratory tract infection of Mycoplasma pneumoniae in children in Northeast
China
WANG Xuefeng, SHANG Yunxiao, CHENG Huanji, WANG Youpeng, FENG Xiaochun, WU Zhenqi, SUN Liping, YANG Nan, QU Shuqiang, WANG Hai, ZHANG Xiuying, CHENG Qi
Chinese Pediatrics of Integrated Traditional and Western Medicine
2023, 15 (6):
461-466.
DOI: 10.3969/j.issn.1674-3865.2023.06.001
In the autumn and
winter of 2023, the number of children with Mycoplasma pneumoniae respiratory
tract infections in Northeast China has increased significantly. In order to
further standardize the clinical prevention and treatment and give full play to
the advantages of integrated traditional Chinese and western medicine
treatment, the construction project team of pediatric pneumonia(a key disease) of the National
Center for Inheritance and Innovation of Traditional Chinese Medicine, and the
pediatric experts of traditional Chinese and western medicine in Northeast
China, by referring to the National Health Commission's Guidelines for the Diagnosis
and Treatment of Mycoplasma Pneumoniae Pneumonia in Children(2023 Edition) and
on the basis of the clinical characteristics of children in the cold regions of
Northeast China, have reached a consensus on the classification of Mycoplasma
pneumoniae respiratory tract infection, the pathogenesis of traditional Chinese
and western medicine, clinical manifestations, imaging and bronchoscopic
manifestations, laboratory examination, early warning of important
complications, and the treatment of traditional Chinese and western medicine in
the infection period, pneumonia period and recovery period. The aim is to
effectively solve the clinical problems of Mycoplasma pneumoniae respiratory
tract infection and improve the comprehensive abilities of pediatricians in the
diagnosis and treatment of Mycoplasma pneumoniae respiratory tract infection,
and then promote the development of integrated traditional Chinese and western
medicine research in Mycoplasma pneumoniae respiratory tract infection.
Related Articles |
Metrics
|
|